149
Views
34
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Effect of remission status and induction chemotherapy regimen on outcome of autologous stem cell transplantation for mantle cell lymphoma

, , , , , , , , & show all
Pages 1062-1073 | Received 07 Nov 2007, Accepted 16 Jan 2008, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Yazeed Sawalha, David A Bond & Lapo Alinari. (2020) Evaluating the Therapeutic Potential of Zanubrutinib in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma: Evidence to Date. OncoTargets and Therapy 13, pages 6573-6581.
Read now
Andre Goy. (2013) Mantle cell lymphoma: continuously improving the odds!. Expert Opinion on Orphan Drugs 1:12, pages 1001-1018.
Read now
Vicent M. Guillem, Cristina Arbona, Juan Carlos Hernández-Boluda, María José Terol, Rosa Goterris, Carlos Solano & Mar Tormo. (2011) An XRCC1 polymorphism is associated with the outcome of patients with lymphoma undergoing autologous stem cell transplant. Leukemia & Lymphoma 52:7, pages 1249-1254.
Read now
Nousheen Samad & Anas Younes. (2010) Temsirolimus in the treatment of relapsed or refractory mantle cell lymphoma. OncoTargets and Therapy 3, pages 167-178.
Read now
Auayporn Nademanee. (2009) Transplantation for non-Hodgkin lymphoma. Expert Review of Hematology 2:4, pages 425-442.
Read now

Articles from other publishers (28)

Pamela McKay, Mike Leach, Bob Jackson, Stephen Robinson & Simon Rule. (2018) Guideline for the management of mantle cell lymphoma. British Journal of Haematology 182:1, pages 46-62.
Crossref
Caitlin Costello, Loren K. Mell & Parag Sanghvi. 2017. Clinical Radiation Oncology. Clinical Radiation Oncology 775 804 .
Robert W. Chen, Hongli Li, Steven H. Bernstein, Samir Kahwash, Lisa M. Rimsza, Stephen J. Forman, Louis Constine, Thomas C. Shea, Amanda F. Cashen, Kristie A. Blum, Timothy S. Fenske, Paul M. Barr, Tycel Phillips, Michael Leblanc, Richard I. Fisher, Bruce D. Cheson, Sonali M. Smith, Malek Faham, Jennifer Wilkins, John P. Leonard, Brad S. Kahl & Jonathan W. Friedberg. (2017) RB but not R-HCVAD is a feasible induction regimen prior to auto-HCT in frontline MCL: results of SWOG Study S1106. British Journal of Haematology 176:5, pages 759-769.
Crossref
Erden Atilla, Pinar Ataca Atilla & Taner Demirer. (2016) Current treatment strategies in relapsed/refractory mantle cell lymphoma: where are we now?. International Journal of Hematology 105:3, pages 257-264.
Crossref
Andre Goy. (2016) Mantle Cell Lymphoma. Hematology/Oncology Clinics of North America 30:6, pages 1345-1370.
Crossref
Mohamed A Kharfan-Dabaja, Tea Reljic, Jessica El-Asmar, Taiga Nishihori, Ernesto Ayala, Mehdi Hamadani & Ambuj Kumar. (2016) Reduced-intensity or myeloablative allogeneic hematopoietic cell transplantation for mantle cell lymphoma: a systematic review. Future Oncology 12:22, pages 2631-2642.
Crossref
Philippe Armand, Robert Redd, Jad Bsat, Sangeetha Mayuram, Angela Giardino, David C. Fisher, Ann S. LaCasce, Caron Jacobson, Matthew S. Davids, Jennifer R. Brown, Li Weng, Jennifer Wilkins, Malek Faham, Arnold S. Freedman, Robin Joyce & Eric D. Jacobsen. (2016) A phase 2 study of Rituximab-Bendamustine and Rituximab-Cytarabine for transplant-eligible patients with mantle cell lymphoma. British Journal of Haematology 173:1, pages 89-95.
Crossref
Jennifer E. Vaughn, Mohamed L. Sorror, Barry E. Storer, Thomas R. Chauncey, Michael A. Pulsipher, Richard T. Maziarz, Michael B. Maris, Parameswaran Hari, Ginna G. Laport, Georg N. Franke, Edward D. Agura, Amelia A. Langston, Andrew R. Rezvani, Rainer Storb, Brenda M. Sandmaier & David G. Maloney. (2015) Long-term sustained disease control in patients with mantle cell lymphoma with or without active disease after treatment with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. Cancer 121:20, pages 3709-3716.
Crossref
Parastoo Bahrami Dahi, Gabriela Soriano Hobbs & Miguel‐Angel Perales. 2015. Clinical Guide to Transplantation in Lymphoma. Clinical Guide to Transplantation in Lymphoma 23 29 .
Alberto Mussetti, Anita Kumar, Parastoo B. Dahi, Miguel-Angel Perales & Craig S. Sauter. (2015) Lifting the mantle: Unveiling new treatment approaches in relapsed or refractory mantle cell lymphoma. Blood Reviews 29:3, pages 143-152.
Crossref
Michał Szymczyk. (2015) Chłoniak z komórek płaszcza – nawrót po leczeniu pierwszej linii. Acta Haematologica Polonica 46:2, pages 112-117.
Crossref
Kami Maddocks & Kristie A. Blum. 2015. Non-Hodgkin Lymphoma. Non-Hodgkin Lymphoma 251 270 .
M Dreyling, S Ferrero & O Hermine. (2014) How to manage mantle cell lymphoma. Leukemia 28:11, pages 2117-2130.
Crossref
D.J. Inwards, P.A. Fishkin, B.R. LaPlant, M.T. Drake, P.J. Kurtin, D.A. Nikcevich, D.B. Wender, B.S. Lair & T.E. Witzig. (2014) Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma. Annals of Oncology 25:10, pages 2020-2024.
Crossref
Timothy S. FenskeMei-Jie ZhangJeanette CarrerasErnesto AyalaLinda J. BurnsAmanda CashenLuciano J. CostaCésar O. FreytesRobert P. GaleMehdi HamadaniLeona A. HolmbergDavid J. InwardsHillard M. LazarusRichard T. MaziarzReinhold MunkerMiguel-Angel PeralesDavid A. RizzieriHarry C. SchoutenSonali M. SmithEdmund K. WallerBaldeep M. WirkGinna G. LaportDavid G. MaloneySilvia MontotoParameswaran N. Hari. (2014) Autologous or Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Chemotherapy-Sensitive Mantle-Cell Lymphoma: Analysis of Transplantation Timing and Modality. Journal of Clinical Oncology 32:4, pages 273-281.
Crossref
Ryan D. Cassaday, Katherine A. Guthrie, Elizabeth L. Budde, Leslie Thompson, Brian G. Till, Oliver W. Press, Thomas R. Chauncey, John M. Pagel, Stephen H. Petersdorf, Maria Corinna Palanca-Wessels, Mary Philip, William I. Bensinger, Leona A. Holmberg, Andrei Shustov, Damian J. Green, Edward N. Libby, David G. Maloney & Ajay K. Gopal. (2013) Specific Features Identify Patients with Relapsed or Refractory Mantle Cell Lymphoma Benefitting from Autologous Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation 19:9, pages 1403-1406.
Crossref
M Hamadani. (2012) Reappraising the role of autologous transplantation for indolent B-cell lymphomas in the chemoimmunotherapy era: is it still relevant?. Bone Marrow Transplantation 48:8, pages 1013-1021.
Crossref
Mehdi Hamadani, Wael Saber, Kwang Woo Ahn, Jeanette Carreras, Mitchell S. Cairo, Timothy S. Fenske, Robert Peter Gale, John Gibson, Gregory A. Hale, Parameswaran N. Hari, Jack W. Hsu, David J. Inwards, Rammurti T. Kamble, Anderas Klein, Dipnarine Maharaj, David I. Marks, David A. Rizzieri, Bipin N. Savani, Harry C. Schouten, Edmund K. Waller, Baldeep Wirk & Hillard M. Lazarus. (2013) Allogeneic Hematopoietic Cell Transplantation for Chemotherapy-Unresponsive Mantle Cell Lymphoma: A Cohort Analysis from the Center for International Blood and Marrow Transplant Research. Biology of Blood and Marrow Transplantation 19:4, pages 625-631.
Crossref
Christian Schmidt & Martin H. Dreyling. 2013. Lymphoma. Lymphoma 157 175 .
Peter Martin, Mitchell Smith & Brian Till. (2012) Management of mantle cell lymphoma in the elderly. Best Practice & Research Clinical Haematology 25:2, pages 221-231.
Crossref
E. Jantunen, C. Canals, M. Attal, K. Thomson, N. Milpied, A. Buzyn, A. Ferrant, P. Biron, C. Crawley, A. Schattenberg, J.J. Luan, H. Tilly, B. Rio, P.W. Wijermans, P. Dreger & A. Sureda. (2012) Autologous stem-cell transplantation in patients with mantle cell lymphoma beyond 65 years of age: a study from the European Group for Blood and Marrow Transplantation (EBMT). Annals of Oncology 23:1, pages 166-171.
Crossref
David J. Inwards & Thomas E. Witzig. (2011) Initial therapy of mantle cell lymphoma. Therapeutic Advances in Hematology 2:6, pages 381-392.
Crossref
Andre Goy & Brad Kahl. (2011) Mantle cell lymphoma: The promise of new treatment options. Critical Reviews in Oncology/Hematology 80:1, pages 69-86.
Crossref
Lihua E. BuddeKatherine A. GuthrieBrian G. TillOliver W. PressThomas R. ChaunceyJohn M. PagelSteven H. PetersdorfWilliam I. BensingerLeona A. HolmbergAndrei R. ShustovDamian J. GreenDavid G. MaloneyAjay K. Gopal. (2011) Mantle Cell Lymphoma International Prognostic Index but Not Pretransplantation Induction Regimen Predicts Survival for Patients With Mantle-Cell Lymphoma Receiving High-Dose Therapy and Autologous Stem-Cell Transplantation. Journal of Clinical Oncology 29:22, pages 3023-3029.
Crossref
Andre Goy. 2011. Management of Hematologic Malignancies. Management of Hematologic Malignancies 308 337 .
Martin Dreyling & Wolfgang Hiddemann. (2009) Current treatment standards and emerging strategies in mantle cell lymphoma. Hematology 2009:1, pages 542-551.
Crossref
. (2008) Current Awareness in Hematological Oncology. Hematological Oncology 26:4, pages 253-260.
Crossref
Franz Buchegger, Oliver W. Press, Angelika Bischof Delaloye & Nicolas Ketterer. (2008) Radiolabeled and Native Antibodies and the Prospect of Cure of Follicular Lymphoma. The Oncologist 13:6, pages 657-667.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.